Why change injection sites for depot antipsychotic medication?

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 8, 2012, Pages 794-

  Cox, Alicia ^a   Emmerson, Brett ^a   Collyer, Bruce ^a   Scott, James ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

DRUG SAFETY; HUMAN; INJECTION SITE; LETTER; MENTAL HEALTH CARE; NURSING PRACTICE; PRACTICE GUIDELINE; DELAYED RELEASE FORMULATION; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; NURSING PROCESS; PERIPHERAL NERVE INJURY; RISK FACTOR; STANDARD;

ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; NURSING PROCESS; PERIPHERAL NERVE INJURIES; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84871852161     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412445024     Document Type: Letter

References (5)

1. Cocoman A, Murray J. Intramuscular injections: a review of best practice for mental health nurses. Journal of Psychiatric and Mental Health Nursing. 2008 ; 15: 424-434
2. Small S. Preventing sciatic nerve injury from intramuscular injections: literature review. Journal of Advanced Nursing. 2004 ; 47: 287-296 (Pubitemid 39090699)
3. Walsh L, Brophy K. Staff nurses' sites of choice for administering intramuscular injections to adult patients in the acute care setting. Journal of Advanced Nursing. 2010 ; 67: 1034-1040
4. Wynaden D, Landsborough I, McGowan S, et al. Best practice guidelines for the administration of intramuscular injections in the mental health setting.. 2006 ; 15: 195-200
5. Zaybak A, Gunes UY, Tamsel S, et al. Does obesity prevent the needle from reaching muscle in intramuscular injections?. Journal of Advanced Nursing. 2007 ; 58: 552-556